Hyponatremia with Olanzapine - A Suspected Association

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Pharmacology

Background:

• Hyponatremia is a rare but serious adverse effect associated with antipsychotic medications.
• Antipsychotics are frequently used in managing schizophrenia and other psychiatric disorders.
• Early identification and management of hyponatremia are critical due to its potentially life-threatening nature.

Observation:

• A 45-year-old female with schizophrenia developed hyponatremia after initiating olanzapine.
• The Naranjo algorithm indicated a probable causal relationship between olanzapine use and the observed hyponatremia.
• The patient's inability to report symptoms or a lack of physician suspicion may delay diagnosis.

Findings:

• Olanzapine is a potential cause of drug-induced hyponatremia.
• The case suggests a probable association between olanzapine and hyponatremia in schizophrenia patients.
• Etiological factors contributing to this adverse event require thorough investigation.

Implications:

• Clinicians should maintain a high index of suspicion for hyponatremia in patients treated with olanzapine.
• This finding underscores the importance of monitoring electrolytes in psychiatric patients on antipsychotics.
• Further research into the mechanisms and prevalence of olanzapine-induced hyponatremia is warranted.